Dominant Companies in the Vietnam Leprosy Market | Insights & Key Players 2026

Dominant Companies in the Vietnam Leprosy Market

The Vietnam leprosy market is a highly specific market segment, that is shaped by a hard-core, government driven national elimination programme, that prioritize fair access and integration of infectious disease control into primary health care. The market relies on a convergence of state health infrastructure, international health agencies, and pharmaceutical suppliers to ensure the regular availability of Multi-Drug Therapy (MDT) and specialized treatment. Major players in the market include the MOH, WHO Vietnam, the NIDV, VSS, VNVC, Traphaco, OPC Pharmaceutical, Cuu Long Pharmaceutical, Sanofi Vietnam and Novartis Vietnam.

Vietnam Leprosy Market Overview

According to 6Wresearch, the Vietnam leprosy market is a well-structured centralized framework, that is controlled by the Ministry of health, to oversee the reduction of residual endemicity. Vietnam has achieved national elimination targets by adopting a highly localized, community-based approach, integrating leprosy management into the broader infectious disease surveillance network at the district and commune levels.

Management of the condition depends on the requirement for consistent, uninterrupted access to MDT supported by state funding and specialized referral systems. Therapies are provided only through accredited public health facilities, and provincial dermatology centres, with the support of digital reporting systems to monitor compliance and drug stock levels in various locations.

Competitive Landscape

The competitive landscape of the Vietnam leprosy industry is characterized by a public-centric model, with strong pharmaceutical procurement partnerships. The Ministry of Health oversees regulatory compliance, and that the public supply chain is stocked with the necessary anti-infective drugs and supportive therapies by local manufacturers and international pharmaceutical companies.

Below is a list of leading players in the Vietnam Leprosy Market:

1. Ministry of Health (MOH) Vietnam

Government agency overseeing the National Leprosy Control Program, surveillance, and drug procurement.

2. World Health Organization (WHO) Vietnam

Provides technical guidance, clinical protocols, and coordinates global donations for MDT.

3. National Institute of Dermatology and Venereology (NIDV)

National reference center for clinical research, leprosy diagnostics, and training for dermatology staff.

4. Vietnam Social Security (VSS)

State-run organization managing insurance funds that cover essential leprosy treatment and clinical management.

5. VNVC (Vietnam Vaccine Joint Stock Company)

Leading provider of immunization services that support general infectious disease immunity and public health programs.

6. Traphaco

Major domestic pharmaceutical company supporting the local supply chain for essential healthcare products.

7. OPC Pharmaceutical

Key domestic manufacturer contributing to the broader anti-infective and supportive pharmaceutical market in Vietnam.

8. Cuu Long Pharmaceutical (DCL)

Domestic pharmaceutical producer focused on high-quality medications that support national health security.

9. Sanofi Vietnam

International pharmaceutical partner supporting local clinical standards and therapeutic solutions for infectious diseases.

10. Novartis Vietnam

Global partner focused on innovative health initiatives and supporting diagnostic/therapeutic improvements for chronic conditions.

Dominant Companies in the Vietnam Leprosy Market: FAQs